10X Genomics
Logotype for 10X Genomics Inc

10X Genomics (TXG) investor relations material

10X Genomics Q3 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for 10X Genomics Inc
Q3 2026 earnings summary5 Nov, 2026

Executive summary

  • Q3 revenue was $150.7M, up 1% YoY; consumables and services growth offset lower instrument and license revenue, while gross margin rose to 75% and net loss narrowed to $19.4M.

  • Atera commercial shipments began in September; strong demand supported raised FY26 guidance, but production, installation and training capacity are expected to constrain the ramp.

Financial highlights

  • Q3 revenue was $150.7M versus $149.0M; products and services revenue rose 1% to $150.2M, while license and royalty revenue fell 54% to $0.5M.

  • Operating loss improved to $16.1M from $32.2M, and net loss narrowed to $19.4M from $27.5M.

  • Operating expenses fell 3% to $129.0M from $132.5M; lower personnel and lab equipment costs were partly offset by higher litigation expenses.

  • 9M revenue declined 5% to $452.5M from $476.8M, while net loss widened to $50.8M from $27.3M.

Outlook and guidance

  • FY26 revenue guidance rose to $625M–$635M from $610M–$630M; excluding non-recurring patent-settlement revenue in FY26 and FY25, expected growth is 4%–6%.

  • Year-end Atera shipment outlook rose to ~50 instruments from ~40; capacity constraints make ~50 per quarter a reasonable 2027 ramp expectation.

  • Q4 gross margin is expected in the low-to-mid 60% range, pressured by product mix and Atera shipments; 2027 margins are expected below current levels as placements precede consumables growth.

  • Q4 spatial consumables are expected to grow at a double-digit rate, including a full quarter of Atera consumables shipments.

  • Planned capital expenditures are $10M–$15M over the next 12 months, mainly for manufacturing and R&D equipment; existing cash and cash generation are expected to cover needs for at least 12 months.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next 10X Genomics earnings date

Logotype for 10X Genomics Inc
Jefferies Global Healthcare Conference17 Nov, 2026
10X Genomics
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next 10X Genomics earnings date

Logotype for 10X Genomics Inc
Jefferies Global Healthcare Conference17 Nov, 2026

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Find what matters

AI across all first-party IR material. Live calls, transcripts, slides, filings.
A cited source card from Adobe's CFO alongside a list of forward-looking statements

Trust every finding

50m+ first-party documents. Every output traceable to its source.

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
An automation set to trigger on the first published earnings document for GE Aerospace

Event-triggered research

Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
An automation scheduled to run weekly on Mondays at 09:00

Scheduled research

Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
A live LVMH Q2 2026 earnings call playing in Quartr

Live earnings calls

Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

Live transcripts

Speaker-by-speaker, in real time. Searchable across every live and historical call.

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

10x Genomics, Inc. is a life science technology company that develops and sells instruments, consumables, and software for analyzing biological systems. The Company's proprietary sequencing technology establishes the framework for interrogating vast amounts of genetic information from thousands of samples at a cost and speed that rivals other sequencing methodology. Its products can obtain billions of sequence reads within a few days to weeks in order to support complex experiments and provide high-quality results that accurately reflect genetic variation across the human genome.